Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

ClinicalTrials.gov ID: NCT02239666

Public ClinicalTrials.gov record NCT02239666. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Study identification

NCT ID
NCT02239666
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
899 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2014 (Actual)
Primary completion
Jan 5, 2017 (Actual)
Completion
Jan 5, 2017 (Actual)
Last update posted
Aug 3, 2017

2014 – 2017

United States locations

U.S. sites
37
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233 —
Research Site Hot Springs Arkansas 71913 —
Research Site Rogers Arkansas 72758 —
Research Site Bakersfield California 93309 —
Research Site Burbank California 91505 —
Research Site Irvine California 92697 —
Research Site Sacramento California 95819 —
Research Site Aurora Colorado 80045 —
Research Site Aventura Florida 33180 —
Research Site Pembroke Pines Florida 33028 —
Research Site Alpharetta Georgia 30022 —
Research Site Macon Georgia 31217 —
Research Site Sandy Springs Georgia 30328 —
Research Site Carmel Indiana 46032 —
Research Site Indianapolis Indiana 46256 —
Research Site Overland Park Kansas 66215 —
Research Site Louisville Kentucky 40202 —
Research Site Owensboro Kentucky 42303 —
Research Site Silver Spring Maryland 20902 —
Research Site Clarkston Michigan 48346 —
Research Site St Louis Missouri 63117 —
Research Site East Windsor New Jersey 08520 —
Research Site New York New York 10016 —
Research Site Rochester New York 14618 —
Research Site Gahanna Ohio 43230 —
Research Site Warren Ohio 44483 —
Research Site Portland Oregon 97239 —
Research Site Philadelphia Pennsylvania 19103 —
Research Site Pittsburgh Pennsylvania 15213 —
Research Site Dallas Texas 75246 —
Research Site Houston Texas 77065 —
Research Site San Antonio Texas 78229 —
Research Site West Jordan Utah 84088 —
Research Site Norfolk Virginia 23502 —
Research Site Roanoke Virginia 24016 —
Research Site Seattle Washington 98101 —
Research Site Bridgeport West Virginia 26330 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02239666, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2017 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02239666 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →